Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Product revenue, net $ 13,030 $ 12,165
Other revenue   48
Total revenue 13,030 12,213
Operating expenses    
Cost of goods sold - product revenue 6,816 6,449
Research and development 7,884 2,033
Selling, general and administrative 8,420 13,292
Total operating expenses 23,120 21,774
Loss from operations (10,090) (9,561)
Other expense (income)    
Interest income (217) (122)
Interest expense 548 650
Foreign exchange transaction losses 21 47
Total other expense (income) 352 575
Loss before income taxes (10,442) (10,136)
Net loss $ (10,442) $ (10,136)
Net loss per common share:    
Basic $ (0.53) $ (0.57)
Diluted $ (0.53) $ (0.57)
Weighted average number of common shares:    
Basic 19,757,449 17,807,194
Diluted 19,757,449 17,807,194